BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...

Investment analysts at HC Wainwright began coverage on shares of Rezolve AI (NASDAQ:RZLV – Get Free Report) in a research ...

H.C. Wainwright analyst Ed Arce affirms a Buy rating on shares of Inventiva (IVA) after the company announced the completion of patient ...

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Talphera (TLPH – Research Report) and Cardiol ...

Sarepta Therapeutics (SRPT) stock drops as the EU officials request a clinical hold on trials involving its gene therapy ...

Analysts have recently evaluated Arcutis Biotherapeutics and provided 12-month price targets. The average target is $19.11, ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $127.72, a high estimate of $202.00, and a low estimate of $75.00. This current ...

Lifecore Biomedical Inc (LFCR) is expected to report $-0.15 for 3Q. Lindsay Corp (LNN) is expected to report $1.89 for 2Q. MSC Industrial Direct Co - A Share (MSM) is expected to report $0.68 for 2Q.